1. Angiotensin Receptor Blockers and the Risk of Malignancy

   • Domenic A. Sica

   Editorial 21 November 2012 Pages: 709 - 712

2. Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

   • Ilan Youngster
   • Lidia Arcavi
   • Matitiahu Berkovitch

   Review Article 21 November 2012 Pages: 713 - 726

   

3. Lactic Acidosis Induced by Metformin

   • Jean-Daniel Lalau

   Review Article 21 November 2012 Pages: 727 - 740

   

4. Identifying Major Congenital Malformations in the UK General Practice Research Database (GPRD)

   • Miss Rachel A. Charlton
   • John G. Weil
   • Corinne S. de Vries

   Short Communication 21 November 2012 Pages: 741 - 750

   

5. Paediatric Postmarketing Pharmacovigilance Using Prescription-Event Monitoring

   • Beate Aurich-Barrera
   • Lynda Wilton
   • Saad Shakir

   Original Research Article 21 November 2012 Pages: 751 - 763

   

6. Completeness of Published Case Reports on Suspected Adverse Drug Reactions

   • Piero Impicciatore
   • Massimiliano Mucci

   Original Research Article 21 November 2012 Pages: 765 - 773

   

7. Adverse Drug Reaction Reporting in the UK

   • David J. McLernon
   • Christine M. Bond
   • Yellow Card Collaboration

   Original Research Article 21 November 2012 Pages: 775 - 788

   

8. Safety Profile of the Fluoroquinolones

   • Francesco Lapi
   • Marco Tuccori
   • Alfredo Vannacci

   Original Research Article 21 November 2012 Pages: 789 - 799

   

9. Book Review

   • David Clark

   BookReview 21 November 2012 Pages: 801 - 802

10. Statins and Muscle Adverse Effects

    • Beatrice A. Golomb
    • Sabrina Koperski
    • Marcella A. Evans

    Correspondence 21 November 2012 Pages: 803 - 803

11. The Authors’ Reply

    • George D. Giannoglou
    • Konstantinos C. Koskinas
    • Yiannis S. Chatzizisis

    Correspondence 21 November 2012 Pages: 803 - 804